Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.

The objective of the present study was to evaluate the potential of paclitaxel loaded micelles fabricated from PEG(5000)-DSPE as a sustained release system following pulmonary delivery. PEG(5000)-DSPE micelles containing paclitaxel were prepared by solvent evaporation technique followed by investigation of in vitro release of paclitaxel in lung simulated fluid. Tissue distribution and plasma pharmacokinetics of the PEG-lipid micelles after intratracheal and intravenous administrations were investigated in addition to intratracheally administered taxol. Finally, toxicological profile of PEG(5000)-DSPE was investigated. Paclitaxel was successfully formulated in PEG-lipid micelles with encapsulation efficiency of 95%. The PEG-lipid micelles exhibited a sustained release behavior in the simulated lung fluid. Intratracheally administered polymeric micellar paclitaxel showed highest accumulation of paclitaxel in the lungs with AUC(0-12) in lungs being 45-fold higher than intravenously administered formulation and 3-fold higher than intratracheally delivered taxol. Paclitaxel concentration in other non-targeted tissues and plasma were significantly lower as compared to other groups. Furthermore, toxicity studies showed no significant increase in levels of lung injury markers in PEG(5000)-DSPE treated group as compared to saline-treated group. PEG(5000)-DSPE micelles delivered intratracheally were able to sustain highest paclitaxel concentrations in lungs for long periods of time, thus apprehending their suitability as pulmonary drug carriers.

[1]  S. Frokjaer,et al.  Drug delivery by phospholipase A(2) degradable liposomes. , 2001, International journal of pharmaceutics.

[2]  G. Oberdörster,et al.  Pulmonary effects of inhaled ultrafine particles , 2000, International archives of occupational and environmental health.

[3]  O.N.M. Mc Callion,et al.  Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers , 1996 .

[4]  J. Malo,et al.  Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma. , 1989, The American review of respiratory disease.

[5]  R. Winn,et al.  Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. , 1993, Journal of the National Cancer Institute.

[6]  V. Torchilin,et al.  Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. , 2006, International journal of pharmaceutics.

[7]  Vladimir P Torchilin,et al.  Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. , 2004, Advanced drug delivery reviews.

[8]  I. El-Sherbiny,et al.  Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres. , 2010, International journal of pharmaceutics.

[9]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[10]  F. Ahsan,et al.  Pulmonary Absorption of Insulin Mediated by Tetradecyl-β-Maltoside and Dimethyl-β-Cyclodextrin , 2003, Pharmaceutical Research.

[11]  S. Antimisiaris,et al.  Liposomes for drug delivery to the lungs by nebulization. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  M. Or.  Simulants of lung interstitial fluid. , 1979 .

[13]  K. Peh,et al.  Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate. , 2006, Journal of nanoscience and nanotechnology.

[14]  David B Warheit,et al.  Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  C. Berkland,et al.  Nanoparticle formulations in pulmonary drug delivery , 2009, Medicinal research reviews.

[16]  W L Hunter,et al.  Solid-state characterization of paclitaxel. , 1997, Journal of pharmaceutical sciences.

[17]  Malgorzata Smola,et al.  Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases , 2008, International journal of nanomedicine.

[18]  S. Nazzal,et al.  Hydrophilic matrices: application of Placket-Burman screening design to model the effect of POLYOX-carbopol blends on drug release. , 2006, International journal of pharmaceutics.

[19]  S. Feng,et al.  Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[20]  H. Montaseri,et al.  Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery. , 2010, Colloids and surfaces. B, Biointerfaces.

[21]  Wei Yang,et al.  Inhaled nanoparticles--a current review. , 2008, International journal of pharmaceutics.

[22]  Mansoor Amiji,et al.  Biodistribution and Targeting Potential of Poly(ethylene glycol)-modified Gelatin Nanoparticles in Subcutaneous Murine Tumor Model , 2004, Journal of drug targeting.

[23]  C. Remuñán-López,et al.  Microencapsulated chitosan nanoparticles for lung protein delivery. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  Q. Guo,et al.  Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. , 2008, Biomaterials.

[25]  Marie-Hélène Dufresne,et al.  Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Y. Zou,et al.  Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non–Small Cell Lung Cancer Xenograft Models , 2004, Clinical Cancer Research.

[27]  Shuhua Bai,et al.  Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. , 2007, Journal of pharmaceutical sciences.

[28]  R. Donehower,et al.  Drug therapy : paclitaxel (Taxol) , 1995 .

[29]  N. Colburn,et al.  Aerosol Delivery of Glucosylated Polyethylenimine/Phosphatase and Tensin Homologue Deleted on Chromosome 10 Complex Suppresses Akt Downstream Pathways in the Lung of K-ras Null Mice , 2004, Cancer Research.

[30]  Vladimir P Torchilin,et al.  Lipid-core micelles for targeted drug delivery. , 2005, Current drug delivery.

[31]  I. Fidler,et al.  Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. , 1980, Cancer research.

[32]  P. Jaques,et al.  Analysis of Total Respiratory Deposition of Inhaled Ultrafine Particles in Adult Subjects at Various Breathing Patterns , 2004 .

[33]  L. Delattre,et al.  Solid lipid microparticles as a sustained release system for pulmonary drug delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  G. P. Martin,et al.  Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  G Pohlmann,et al.  A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[36]  V. Torchilin,et al.  Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[37]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Sung Chul Kim,et al.  Sensitive HPLC method for quantitation of paclitaxel (Genexol in biological samples with application to preclinical pharmacokinetics and biodistribution. , 2005, Journal of pharmaceutical and biomedical analysis.

[39]  E. Golunski,et al.  Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  G. Kwon,et al.  Polymeric micelles for drug delivery. , 2006, Current pharmaceutical design.

[41]  C. Belani.  Paclitaxel and docetaxel combinations in non-small cell lung cancer. , 2000, Chest.

[42]  J. Hanes,et al.  New polymeric carriers for controlled drug delivery following inhalation or injection. , 2002, Biomaterials.

[43]  L. J. Krenis,et al.  Effect of Size and Concentration of Latex Particles on Respiration of Human Blood Leucocytes.∗ , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[44]  Lise Arleth,et al.  In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. , 2004, Journal of pharmaceutical sciences.

[45]  B. Pulliam,et al.  Nanoparticles for drug delivery to the lungs. , 2007, Trends in biotechnology.

[46]  Xiao-ling Fang,et al.  Biodistribution in mice and severity of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomes. , 2008, Pulmonary pharmacology & therapeutics.

[47]  E. Golunski,et al.  Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. , 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[48]  I. Kellaway,et al.  Novel sustained release microspheres for pulmonary drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[49]  Mansoor M. Amiji,et al.  Nanotechnology for Cancer Therapy , 2006 .

[50]  Ho-Chul Shin,et al.  Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. , 2009, Journal of controlled release : official journal of the Controlled Release Society.